Navigation Links
Genetic Test Shows Promise in Guiding Breast Cancer Care
Date:5/10/2011

respond to this chemotherapy did, in fact, survive three years without a relapse, giving them an 18 percent lower risk of dying compared to those identified as "non-responders" to the treatment.

And, Symmans said, "at three years, breast cancer had not returned in 97 percent of women with ER-positive and 83 percent of women with triple-(ER) negative breast cancer if they were predicted to be treatment-sensitive. If they were predicted to be treatment-insensitive, the rates were 86 percent and 57 percent, respectively."

The study was funded by Susan G. Komen for the Cure and the U.S. National Cancer Institute, among others. Several of the authors also hold patents with Nuvera Biosciences, Inc., which was involved in the test.

"This study is not the definitive final word on the subject, but it offers a totally new way of looking at the question of how do we predict whose tumor is really sensitive to chemotherapy, whose tumor is probably resistant to chemo or neither of the above," said Symmans.

One expert called the study just one "baby step" on the path towards more individualized treatments for patients. "I don't know if this is enough to propel people to use this," said Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City.

The test, while promising, is "not ready for patients," agreed Dr. Massimo Cristofanilli, professor and chairman of medical oncology at Fox Chase Cancer Center in Philadelphia. Nor does it predict which therapy will be best, he added.

But depending on further research, the test may one day be valuable in helping women and their doctors make difficult decisions regarding treatment, as opposed to today, when so much is guesswork. "It's important to me to not give to have to give 100 women chemotherapy to save 10 or 15 lives," Shapira explained. "It's important to me to be able to identify the 10 or 15 patients who are going to benefit from chemotherapy."

More info
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Genetic information may help predict likelihood of survival following chemotherapy for breast cancer
2. Genetic defects hold clues to risk for sudden cardiac death
3. New guidelines for cardiovascular genetic testing
4. Epigenetic study reveals new insights into breast cancer
5. Mayo Clinic finds new genetic cause of neurodegeneration
6. New class of cancer drugs could work in colon cancers with genetic mutation, U-M study finds
7. Liver-cell transplants show promise in reversing genetic disease affecting liver and lungs
8. Hope for children with rare genetic defect
9. Parents Want Genetic Testing for Kids: Study
10. Intellectual disability is frequently caused by non-hereditary genetic problems
11. Study: Parents likely to embrace predictive genetic testing for their children if offered
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Test Shows Promise in Guiding Breast Cancer Care
(Date:6/2/2015)... 2015 ANT Wireless, proven innovator in ... of two new products implementing the ANT+ Fitness Equipment ... wireless interoperability in their bike trainer products, built to ... has implemented the FE-C device profile in its Vortex ... its new indoor training software, while Kinomap has added ...
(Date:6/2/2015)... HILLSBORO, OR (PRWEB) June 02, 2015 ... creator of ZOOM+ Performance Health Insurance, announced today the ... Healthy Clean White 57 - a three-in-one complete dental ... Healthy Clean Jr. for kids. Like all ZOOM+ services, ... , “Why shouldn’t the dentist office be as ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 With a dedicated ... Living & Health Care has hired Leslie Young as ... of human resource initiatives to better understand and respond to ... in Tutera’s 47 communities in 13 states across the country. ... levels of personalized support to our residents, we are making ...
(Date:6/2/2015)... 2015 ANT Wireless, proven innovator ... Pole Engineering’s (NPE) announcement of three next generation ... WASP-PoE-2 and WASP-PoE-3. WASP is a standalone ANT ... bridge solution that allows data collected from low-power ... Ethernet networks. , The new generation ...
(Date:6/2/2015)... For those that have ever worried that ... germs, chemicals and bodily fluids from each flush, their ... from Queens Village, N.Y., their worries are over. , ... hygienic way to store and dispense toothpaste. It also ... and germs. Furthermore, it insures that all contents of ...
Breaking Medicine News(10 mins):Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 3Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2
... , , , , ... Cleveland Clinic Lou Ruvo Center for Brain Health welcomes ... highly touted model of patient-focused care. , , ... Health is a highly specialized clinical center designed to advance the research, early ...
... Va., July 13 Long term care costs in most ... putting significant financial pressure on those in or near retirement. ... Genworth offers a suite of insurance products to help people ... in Arkansas can take advantage of a new program designed ...
... , , , ... BMRN ) announced today that patient enrollment has been ... 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder ... company expects to report initial results in the first half of ...
... of lives, researchers say , MONDAY, July 13 (HealthDay ... have died because of safety restrictions on the ... study suggests. , Finnish researchers concluded that clozapine is ... antipsychotics. , For this study, the researchers looked at ...
... , LOS ALTOS, Calif., July 13 InteKrin ... as Chief Business Officer. Most recently, Mr. Parker served as ... Goldman, Sachs & Co. Over the past ten years, Mr. ... which time he advised many of the biotechnology industry,s leading companies. ...
... (NYSE: HAE ) will announce its Q1FY10 earnings on August 3, ... , Webcast Link: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=2323195 ... from August 3, 2009 after 1:00 pm to August 10, 2009. , ... Julie Fallon, Tel. (781) 356-9517, Alt. Tel. ...
Cached Medicine News:Health News:Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business 2Health News:Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business 3Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Arkansas AARP Members 2Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Arkansas AARP Members 3Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Arkansas AARP Members 4Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Arkansas AARP Members 5Health News:Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome 2Health News:Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome 3Health News:Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome 4Health News:Schizophrenia Drug Got Bad Rap 2Health News:InteKrin Therapeutics Announces Appointment of Geoffrey M. Parker as Chief Business Officer 2
(Date:6/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/d8nj6b/europe ) ... Market - Growth, Trends And Forecasts (2014 - 2019)" ... market for Fluoroscopy is expected to grow at a ... is used to view the gastrointestinal tract, to direct ... ducts or the urinary system, to open narrowed or ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/w3n5p6/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. The delivery of drugs to ... the treatment of neurological disorders. Drugs may be ... (e.g., by intravenous injection) for targeted action in ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/z9s8mp/laboratory ) has ... - Global Strategic Business Report" report to ... are provided for the period 2014 through 2020. ... these markets. Market data and analytics are derived ... primarily based on public domain information including company ...
Breaking Medicine Technology:European Fluoroscopy Market Report 2014-2019 - Growth, Trends And Forecasts 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2
Sabre 180 is a powerful niche generator....
Sabre 180 is a powerful niche generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
Medicine Products: